Abstract

The present study was planned to investigate the plasma disposition kinetics and the pattern of moxifloxacin elimination in the milk of lactating ewes ( n = 6) following a single intravenous (IV) bolus or intramuscular (IM) injections at a dosage of 5 mg/kg in all animals. A crossover study was carried out in two phases separated by 21 days. Plasma and milk samples were collected serially for 72 h and moxifloxacin concentrations were assayed using high performance liquid chromatography with fluorescence detection. A two-compartment open model best described the decrease of moxifloxacin concentration in the plasma after IV injection. The disposition after IM administration moxifloxacin was best described by a one-compartment model. Following IV administration, the distribution half-life ( t 1/2 α ) was 0.22 ± 0.02 h. The elimination half-life was 1.77 ± 0.23 h. The volume of distribution at steady state ( V dss) was 0.84 ± 0.12 L/kg, the total body clearance (Cl tot) was 0.34 ± 0.04 L/h/kg and the area under the curve (AUC) was 14.74 ± 2.16 μg h/mL. Following IM administration, the mean T max, C max, t 1/2el and AUC values for plasma data were 1.45 ± 0.02 h, 2.21 ± 0.27 μg/mL, 2.68 ± 0.19 h and 14.21 ± 2.35 μg h/mL. The IM bioavailability was 96.35 ± 17.23% and the in vitro protein binding of moxifloxacin ranged from 32–37%. Penetration of moxifloxacin from the blood into milk was rapid and extensive, and the moxifloxacin concentrations in milk exceeded those in plasma from 1 h after administration. The kinetic values AUC milk/AUC plasma and C max milk / C max plasma ratios indicated a wide penetration of moxifloxacin from the bloodstream to the mammary gland. The in vitro minimum inhibitory concentration (MIC) of moxifloxacin for Mannheimia haemolytica was found to be 0.035 μg/mL.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call